V-Square Quantitative Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$315K Buy
1,403
+100
+8% +$24.9K 0.03% 420
2025
Q4
$314K Buy
+1,303
New +$333K 0.03% 417
2025
Q3
Sell
-1,747
Closed -$451K 500
2025
Q2
$451K Buy
1,747
+51
+3% +$12.2K 0.06% 320
2025
Q1
$380K Buy
1,696
+10
+0.6% +$2.33K 0.06% 363
2024
Q4
$386K Sell
1,686
-33
-2% -$7.95K 0.05% 361
2024
Q3
$420K Buy
1,719
+171
+11% +$38.2K 0.06% 344
2024
Q2
$296K Sell
1,548
-335
-18% -$68K 0.05% 366
2024
Q1
$373K Buy
1,883
+575
+44% +$105K 0.05% 330
2023
Q4
$225K Hold
1,308
0.04% 396
2023
Q3
$193K Buy
+1,308
New +$237K 0.09% 363
2023
Q2
Sell
-915
Closed -$200K 478
2023
Q1
$200K Buy
+915
New +$199K 0.18% 139

Other funds holding RMD

V-Square Quantitative Management's RMD Position: Q1 2026 in Review

V-Square Quantitative Management increased its ResMed (RMD) stake by 7.7% in Q1 2026, buying an estimated $24.9K and bringing the position to 1,403 shares worth $315K. The position accounts for 0.03% of the portfolio, ranked #420.

V-Square Quantitative Management first reported a position in RMD in Q1 2023 and has held it in 11 quarters since. The position peaked at $451K in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • V-Square Quantitative Management held 1,403 shares of ResMed worth $315K as of Q1 2026.
  • V-Square Quantitative Management bought 100 ResMed shares in Q1 2026, an estimated $24.9K.
  • ResMed made up 0.03% of V-Square Quantitative Management's portfolio in Q1 2026, its #420 holding.
  • V-Square Quantitative Management first reported a position in ResMed in Q1 2023 and has held it in 11 quarters since.
  • V-Square Quantitative Management's ResMed position peaked at $451K in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on V-Square Quantitative Management's 13F filing for Q1 2026, filed 27 Apr 2026.